Skip to content
EUAILaw.com
Articles / Annexes

Chapter I — GENERAL PROVISIONS

Chapter II — PROHIBITED AI PRACTICES

Chapter III — HIGH-RISK AI SYSTEMS

Chapter IV — TRANSPARENCY OBLIGATIONS FOR PROVIDERS AND DEPLOYERS OF CERTAIN AI SYSTEMS

Chapter VIII — EU DATABASE FOR HIGH-RISK AI SYSTEMS

Chapter IX — POST-MARKET MONITORING, INFORMATION SHARING AND MARKET SURVEILLANCE

Chapter XI — DELEGATION OF POWER AND COMMITTEE PROCEDURE

Annexes

Recitals →
Artificial Intelligence Act·Recital 147

Recital (147)

Recitals 147 / 180

It is appropriate that the Commission facilitates, to the extent possible, access to testing and experimentation facilities to bodies, groups or laboratories established or accredited pursuant to any relevant Union harmonisation legislation and which fulfil tasks in the context of conformity assessment of products or devices covered by that Union harmonisation legislation. This is, in particular, the case as regards expert panels, expert laboratories and reference laboratories in the field of medical devices pursuant to Regulations (EU) 2017/745 and (EU) 2017/746.